3 Apr 2018 16:03
UK Earnings, Trading Statements Calendar - Next 7 Days
Wednesday 4 April RenewiTrading statementNext Fifteen Communications GroupFull Year 5 (at
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
LID.L Share News (LID)
LID Share
Price
LID Share
News
LID Share
Chat
LID Share
Trades
LID
Live RNS
LID Share
Charts
LID Broker
Ratings
LID Directors
Deals
LID Financial
Diary
LID
Fundamentals
LID Short
Positions
LID
Media
LID.L Information
- There is currently no data for LID
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group
Thu, 23rd Aug 2012 16:00
Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p. The company's Chairman said the period was one of "significant operating progress" in what has been a challenging period for investing in Indian infrastructure and stressed that it has diversified and increased the size of its portfolio. Drug firm SkyePharma posted a strong rise in net profit after tax for the half year ended June 30th from £0.4m to £3.4m after research and development expenses fell from £10.1m to £6.3m and boosted by income from discontinued operations. Revenues were down 10%, in line with expectations, from £22.1m to £19.8m. Pre-exceptional earnings before interest, tax, depreciation and amortisation (EBITDA) from continuing operations were £4.9m (H1 2011: £4.2m). Cash at the end of the period fell £15.2m to £11.0m. LiDCO Group, a cardiovascular monitoring company, expects its results for the six months to July 31st to show a four per cent increase in revenue at £3.3m, with cash at the period end at £1m. Product sales were up by 18%, while sales in the UK increased overall by 49%, with both LiDCO and Argon distributed product sales increasing well. Surgical disposables unit sales in the UK showed a significant and encouraging increase of 33%. NR
More News
14 Feb 2017 12:46
LiDCO posts extensive trading update
(ShareCast News) - Cardiovascular monitoring company LiDCO Group provided a trading update for the full year to 31 January on Tuesday, with product revenues in the period expected to be up 14% to £6.76m, with total revenues - including third party products - expected to be up by 8% to £8.21m. The AI
Read more14 Feb 2017 09:11
10 Jan 2017 11:50
LiDCO appoints Shane Doorish as head of North America
(ShareCast News) - Hemodynamic monitoring company LiDCO announced the appointment of Shane Doorish as head of North America on Tuesday, with immediate effect. The AIM-traded firm said Doorish was bringing with him 19 years of experience in the healthcare sector having originally trained as a critica
Read more16 Dec 2016 16:10
11 Oct 2016 11:37
LiDCO narrows loss in first half
(ShareCast News) - Hemodynamic monitoring company LiDCO announced its unaudited interim results for the six months to 31 July on Tuesday, with product revenues up 10% to £3.03m. The AIM-traded firm's total product revenues, including third party products, was up 5% to £3.77m, with US revenues up 37%
Read more18 May 2016 15:05
16 May 2016 14:18
Lidco inks US distribution deal with ICU Medical
(ShareCast News) - LiDCO has inked a distribution agreement with partner ICU Medical to sell the LiDCO IM non-invasive hemodynamic monitoring system in the US. LiDCO IM is a specially configured hemodynamic monitor produced exclusively for ICU Medical. It works solely in conjunction with LiDCO's non
Read more21 Apr 2016 16:38
LiDCO shows off new hemodynamic monitoring tech
(ShareCast News) - Hemodynamic monitoring company LiDCO was busy in the US capital this week, showing off its new technology LiDCOunity monitor at the 2016 Annual Congress of Advanced Recovery and Perioperative Medicine. The conference is currently being held in Washington, D.C. LiDCO's board said
Read more